ADIL - CIK 0001513525
ADIAL PHARMACEUTICALS, INC. has filed 533 documents with the SEC between 2011 and 2026. The most frequent type is major company event (143 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| Major company event | 8-K | 2026-05-11 | 2026-05-11 |
| Quarterly report | 10-Q | 2026-05-08 | 2026-03-31 |
| Major company event | 8-K | 2026-04-09 | 2026-04-07 |
| Insider trade | 4 | 2026-04-09 | 2026-04-07 |
| Insider trade | 4 | 2026-04-09 | 2026-04-07 |
| Insider trade | 4 | 2026-04-09 | 2026-04-07 |
| Insider trade | 4 | 2026-04-09 | 2026-04-07 |
| Insider trade | 4 | 2026-04-09 | 2026-04-07 |
| Insider trade | 4 | 2026-04-09 | 2026-04-07 |
| Major company event | 8-K | 2026-03-06 | 2026-03-06 |
| Annual report | 10-K | 2026-03-05 | 2025-12-31 |
| Major company event | 8-K | 2026-03-03 | 2026-02-26 |
| Major company event | 8-K | 2026-02-24 | 2026-02-23 |
| SCHEDULE 13G | - | 2026-02-18 | - |
| Major company event | 8-K | 2026-02-04 | 2026-02-03 |
| Proxy statement | DEF 14A | 2026-01-06 | 2026-02-26 |
| Major company event | 8-K | 2026-01-06 | 2026-01-05 |
| PRE 14A | - | 2025-12-23 | 2025-12-23 |
| Prospectus supplement | 424B5 | 2025-12-19 | - |
| EFFECT | - | 2025-12-17 | - |
| Company correspondence | CORRESP | 2025-12-15 | - |
| Securities registration | S-3 | 2025-12-12 | - |
| D | - | 2025-12-03 | - |
| Major company event | 8-K | 2025-12-01 | 2025-11-25 |
| Major company event | 8-K | 2025-11-14 | 2025-11-14 |
| Quarterly report | 10-Q | 2025-11-13 | 2025-09-30 |
| Major company event | 8-K | 2025-09-16 | 2025-09-16 |
| Employee stock plan | S-8 | 2025-09-09 | - |
| Major company event | 8-K | 2025-09-03 | 2025-09-02 |
| Major company event | 8-K | 2025-08-14 | 2025-08-14 |
| Quarterly report | 10-Q | 2025-08-13 | 2025-06-30 |
| Prospectus supplement | 424B5 | 2025-08-01 | - |
| Major company event | 8-K | 2025-08-01 | 2025-07-31 |
| Major company event | 8-K | 2025-08-01 | 2025-08-01 |
| Prospectus supplement | 424B5 | 2025-07-31 | - |
| Major company event | 8-K | 2025-07-16 | 2025-07-14 |
| Major company event | 8-K | 2025-07-10 | 2025-07-09 |
| DEFR14A | - | 2025-06-27 | - |
| SCHEDULE 13G | - | 2025-06-23 | - |
| Major company event | 8-K | 2025-06-18 | 2025-06-16 |
| Prospectus supplement | 424B5 | 2025-06-18 | - |
| PRER14A | - | 2025-06-17 | - |
| EFFECT | - | 2025-06-16 | - |
| Major company event | 8-K | 2025-06-16 | 2025-06-16 |
| S-1/A | - | 2025-06-13 | - |
| Company correspondence | CORRESP | 2025-06-12 | - |
| Company correspondence | CORRESP | 2025-06-12 | - |
| Annual report to shareholders | ARS | 2025-06-10 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-06-10 | 2025-07-24 |